Price and states served both move. Read them off the seller's own site before you enroll.How our reviews work →

Brello Health vs MEDVi

Brello Health costs $91.28 less a month, and both sell semaglutide.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

By Ruth Calder · Enforcement Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
Brello Health logo

Brello Health

7.4
★★★★☆3.7/5

Best for: seeing what it charges before you answer any medical questions

Visit Brello Health →
VS
MEDVi logo

MEDVi

7.1
★★★★☆3.6/5

Best for: knowing which pharmacy fills the vial: it names Triad Rx

Visit MEDVi →

If you are choosing between Brello Health and MEDVi, the first difference is cost: Brello Health is $91.28 a month cheaper at the entry price. Both prescribe semaglutide, so moving from one to the other would not change your drug. Brello Health leads our six-part score, 7.4 to 7.1. One of the two has an FDA warning letter on record, covered below.

Brello Health vs MEDVi price

Brello Health is the cheaper way in: $157.72 a month against $249 a month at MEDVi. That is $91.28 less each month (37% lower), or about $1,095.36 over a year of treatment.

Drug by drug: Semaglutide is cheaper at Brello Health ($157.72 a month vs $249 a month).

Medications and formats

Both sell semaglutide.

On format they match: each offers compounded injections.

Where each one treats patients

Brello Health lists 35 states, and MEDVi lists 48 states.

They overlap in 32 states. Brello Health alone covers District of Columbia, Mississippi and North Dakota. MEDVi alone covers 16 states, including Alabama, Arkansas, California and Connecticut.

Pricing

Brello Health

Compounded semaglutide, billed $399 every 11 weeksCompounded
$157.72/mo
semaglutide

MEDVi

Compounded GLP-1 Injection (weekly)Compounded
$299$179/mo
Save 40% right now
semaglutide

Refills are locked in at $299. The first month is $179 in the 'SUMMER Sale,' and some MEDVi landing pages offer the first month at $149.

Compounded GLP-1 Tablets (daily dissolvable)Compounded
$249/mo
semaglutide

Flat 'Starting at $249' — no intro discount shown.

Wegovy Pill / Wegovy Injection (membership fee only; medication cost not published)Brand-name
$99/mo
semaglutide

$99 Membership + Medication Cost — medication cost not published (varies/insurance may reimburse). 'Availability is subject to change.'

Zepbound Injection (membership fee only; medication cost not published)Brand-name
$99/mo
tirzepatide

$99 Membership + Medication Cost — medication cost not published. COMPOUNDED tirzepatide ($349 in our current entry) is no longer published anywhere on glp1.medvi.org, home.medvi.org, or the intake flow (0 mentions) — treat as discontinued/not published, do not carry the $349 row forward.

What each price covers

Both prices cover the clinician visit and the medication itself.

MEDVi's price also covers shipping and coaching, which Brello Health does not claim.

Brello Health is silent on shipping, lab work and coaching.

MEDVi is silent on lab work.

Brello Health

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

Not stated

Lab work

Not stated

Coaching

Not stated

MEDVi

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

In the price

Lab work

Not stated

Coaching

In the price

Where each one scores higher

Overall, Brello Health scores 7.4 and MEDVi 7.1 out of 10.

Brello Health is stronger on value (6.1 vs 2.8) and trust & safety (8.5 vs 6.0).

MEDVi is stronger on effectiveness (10.0 vs 8.5), accessibility (9.7 vs 7.6) and support (8.5 vs 5.5).

User experience is within half a point.

How we score

Brello Health

7.4/10

Overall

MEDVi

7.1/10

Value25%

6.1A
vs
B
2.8

Effectiveness25%

8.5A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

8.5A
vs
B
6.0

Accessibility10%

7.6A
vs
B
9.7

Support10%

5.5A
vs
B
8.5

FDA warning letters

The FDA sent MEDVi a warning letter dated February 20, 2026 (letter 721455), and it is still open.

Brello Health has no FDA warning letter on record with us.

Features & Coverage

FeatureBrello HealthMEDVi
Starting Price✓$157.72/mo$249/mo
Features2 features✓7 features
States Available35✓48
Compounded✓ Yes✓ Yes
Brand Name—✓ Yes
FSA/HSA Accepted——
FDA Warning Letters✓None1 letter

About Brello Health

Brello Health is a telehealth wellness platform selling GLP-1 weight management.

Read our full Brello Health review →

About MEDVi

Two clinical groups do the treating at MEDVi: CareGLP Affiliated P.C.s, plus clinicians from OpenLoop Health. Its weight-loss menu holds compounded GLP-1s, injections and tablets alike, the molecule being semaglutide, next to Zepbound and Wegovy under their brand names. Licensed US pharmacies fill all of it.

Read our full MEDVi review →

Pros & Cons

Brello Health

What we like

  • Semaglutide costs $157.72 a month, 14% below the $184 median for compounded semaglutide across the sellers we compare
  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price includes the medication and clinician visits
  • We found no FDA warning letters issued to Brello Health

Watch-outs

  • Serves only 35 states, so check that yours is one of them
  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality

MEDVi

What we like

  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price includes the medication, clinician visits, shipping and coaching
  • Serves 48 states
  • Names 3 pharmacies that fill its prescriptions, which most sellers do not

Watch-outs

  • Semaglutide costs $249 a month, 35% above the $184 median for compounded semaglutide across the sellers we compare
  • The FDA has issued MEDVi a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
  • Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality

Our Verdict

Winner: Brello Health

Brello Health wins this one, 7.4 to 7.1, above all for seeing what it charges before you answer any medical questions. It also costs $91.28 less each month than MEDVi. MEDVi fits better if knowing which pharmacy fills the vial: it names Triad Rx is your priority.

Choose Brello Health if…

You want seeing what it charges before you answer any medical questions and an opening price near $157.72 a month.

Choose MEDVi if…

You want knowing which pharmacy fills the vial: it names Triad Rx and an opening price near $249 a month.

Ready to start? GLP-1 providers we have vetted

Telehealth providers, vetted by us, prescribing GLP-1 online.

Vetted by our editors · no insurance required

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

6.5

Sesame Care

Oral orforglipron alongside the injectables

8.4

Collective

Flat any-dose pricing, if you can absorb a $199 annual membership on top

8.6

Found

Tirzepatide at $169/month, 37% below the typical price

Brello Health vs MEDVi: FAQ

Brello Health. It starts at $157.72 a month; MEDVi starts at $249 a month, $91.28 more per month.
Yes, both sell semaglutide.
MEDVi: 48 states against 35, with 32 in common.
Both include the clinician visit and the medication itself. Only MEDVi includes shipping and coaching.
Brello Health has none. MEDVi has an open FDA warning letter from February 20, 2026.
No. Neither Brello Health nor MEDVi pays us anything.

Or see the full category ranking.